TERMS AND CONDITIONS
Email for further information: [email protected]
Efficacy and Mechanism Demonstration with Unique
Patented High Sensitivity Multiplexing Technology
The activity is conducted according to the principles of GLP and ISO 17025:2005 compliance in conjunction with internal and external independent Quality Assurance.
Aeirtec provides unique patented high sensitivity multiplexed marker assay technology (femtogram/ml) in a wide range of clinical studies including now COVID-19 cytokine storm. This is delivered within a modular way of working, with either pre-determined marker panels, or Aeirtec custom-made panels from our advise on design, according to the clinical condition. Data delivered can then be analysed by us through a range of multivariate bioinformatic analyses to amplify mechanism discovery and therapeutic efficacy.
The panel assays are validated prior to study sample analysis. Each marker assay conducted on samples is accompanied by measurements of lower and upper limits of quantification (LLOQ and ULOQ) derived from calibration curves conducted at the time of sample analysis.
High sensitivity assay technology